Skip to main content
Caplight Logo









Philophos

Philophos

Private
DaejeonHealthcare & Life Scienceshttps://philophos.com

Last Round

Series A

Jan 24, 2022

Total Funding Raised

$1.51M

Company Overview

Philophos is a medical device company that develops and manufactures portable, low-cost optical coherence tomography (OCT) systems for medical diagnostics and tele-ophthalmology applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices, Sensors, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

optical coherence tomographyOCTportable medical devicespoint-of-care diagnosticstele-ophthalmologyhandheld OCTretinal imagingdermatological imagingmedical imaging hardwareOCT spectrometerindustrial inspectionOEM componentsremote diagnosticsmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Philophos Comparables

Compare Philophos with similar companies based on industry and business-model similarity.

Philophos comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tishyas Medical Device Development Solutions
88%
Lumedica, Inc.
87%
Lumedica Vision
87%

Philophos Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 24, 2022
Pre SeedOct 17, 2019
AcceleratorMay 21, 2019

Key People

Founding team and executive leadership

Jung-Ho Chung

CEO & founder

Founding Team

Hyunho Oh

Chief Technology Officer

Executive Team

Philophos Investors

Notable investors and investment history

Philophos investors
InvestorRounds
Bluepoint PartnersPre Seed
Dadam InvestmentSeries A
ETRI HoldingsPre Seed
Industrial Bank of KoreaAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 24, 2022

    Raised $1.51M from Dadam Investment and kban-or.

  • Oct 17, 2019

    Raised Pre Seed round with Bluepoint Partners and ETRI Holdings.

Philophos Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Philophos Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Philophos's valuation, stock price, and market status.

Firmographic Details

HeadquartersDaejeon
Employee Range6
Year Founded2018
Last FundingJan 24, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?